11
Sep
2015
Post-Labor Day Hangovers, Ipi-Nivo Combo Data & the PCSK9 Pricing Debate
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
8
Sep
2015
Medical Device Innovation Is on Life Support. What Will Revive It?
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
4
Sep
2015
Insider Selling at Biotech’s Highflying IPOs From 2013-2014
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
1
Sep
2015
Join Me for the TR San Francisco Launch Party Oct. 20
I’m coming to San Francisco next month, and looking forward to a party. Mark your calendars for 5 pm Oct. 20 for the Timmerman Report’s San Francisco Launch Party. This special event will be held at Invitae at 475 Brannan St. in SF’s SoMa district. It will be free, but requires an advance RSVP. San Francisco Bay Area readers have... Read More
31
Aug
2015
What Happens After the Hype? A Few Survive the ‘Trough of Disillusionment’
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
28
Aug
2015
Insider Stock Sales at Biotech’s Big Six: See Who’s Cashing Out the Most
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
25
Aug
2015
How to Get Corporate/Group Subscriptions to Timmerman Report? It’s Easy
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
24
Aug
2015
Informed Consent Isn’t Working. Sage, Apple Just Might Be Onto Something Better
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
21
Aug
2015
A Day In the Life of a Biotech Building: 1616 Eastlake
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
19
Aug
2015
Not Just Research, Not Just Diagnostics: Adaptive Veers into T-Cell Drug Discovery
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
17
Aug
2015
Amarin vs. the FDA on Free Speech: A Careful-What-You-Wish-For Moment
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
12
Aug
2015
Important Note for TR Subscribers: Please Re-Register
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
10
Aug
2015
‘Pharmaphobia’ Pushes Back Against Anti-Industry Crusade, But Comes Up Short
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
6
Aug
2015
Making Biotech Drugs People Can Afford: KUOW Radio Segment
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
4
Aug
2015
Molecular Information Companies, One Way or Another, Find Value in Genomics
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
31
Jul
2015
Join Me for TR Subscriber Meetup Aug. 5 in Kendall Square
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
29
Jul
2015
Data From Texas: VCs, Still Mostly Underwater, Ride Stocks As Long As Possible
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
27
Jul
2015
Bad Behaviors Creeping Into Biotech During the Boom
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
24
Jul
2015
The Amgen Seattle Alumni: Where Are They Now?
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
21
Jul
2015
The Non-Compete Chill Has Passed: Bristol-Myers, MedImmune Settle Over I-O Star
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.